News

Guggenheim Boosts FOX Corp Price Target After Impressive Q1

Guggenheim Boosts FOX Corp Price Target After Impressive Q1

Guggenheim Increases Price Target for FOX Corp.

Guggenheim has reaffirmed its Buy rating on FOX Corp. (NASDAQ: FOXA) and raised the price target to $50 from the previous $45. This optimistic adjustment comes after the company's impressive fiscal first-quarter results, which exceeded both Guggenheim's expectations and those of analysts. The strong performance was largely attributed to notable growth across its business segments, particularly in Cable Networks.

Strong Revenue Growth Driven by Political Advertising

FOX Corp. experienced a robust revenue growth surge of 11% in the recent quarter, a significant increase compared to just 2% growth in the preceding quarter. Multiple factors contributed to this remarkable growth, particularly a record in political advertising. The company’s political ad revenue outpaced figures from the last election cycle, even surpassing the Georgia Senate runoff results from 2020. Another driving factor was the 47% hike in 'Other' revenue, contrasting an 11% decline from the prior quarter, which was largely due to changes in sublicensing timing. Improvement in affiliate revenue can also be credited to effective pricing strategies and a slowdown in subscriber losses.

Tubi's Exceptional Performance in Streaming

A shining example of the company's growth is its ad-supported streaming service, Tubi, which reported a 19% increase in revenue. This growth has been impressive, even excluding revenues related to political advertising. Management has indicated that this upward trend is expected to persist into the next fiscal quarter. Leaders at FOX Corp. have underscored strong audience engagement, particularly within their News segment, as a critical driver of this success.

Looking Ahead to Upcoming Events

Looking forward, Guggenheim is focusing on the fiscal year 2025 as a pivotal year for FOX Corp., anticipating that the company will benefit from various major events, including the World Series, the U.S. election cycle, and Super Bowl LIX. The elevated price target to $50 reflects this optimism, underscored by higher revenue forecasts for the company.

Recent Analyst Upgrades Strengthen Outlook

In other noteworthy developments, an analyst from CFRA upgraded FOX Corp. from 'Sell' to 'Hold' and increased the price target to $46, following a strong showing in their September quarter results. The firm revised upwards its earnings per share (EPS) estimates for the fiscal years 2025 and 2026, further emphasizing the strong trajectory of FOX Corp.

Quarterly Financial Performance Exceeds Expectations

For the September quarter, FOX Corp. reported an EPS of $1.78, significantly surpassing the consensus estimate of $1.13. This impressive performance can be attributed to an overall 5.6% increase in revenues, bolstered by the ongoing election news cycle and live sports events. The company reported a quarterly revenue total of $3.56 billion, exceeding initial forecasts of $3.37 billion. Notably, FOX's Cable Network Programming division brought in $1.60 billion, well above analysts' expectations.

Financial Health and Market Position

Recent insights about FOX Corp.'s financial standing show a company well-positioned in the market. As of the recent reports, FOX has maintained a healthy balance sheet, holding $4.1 billion in cash and cash equivalents against a debt load of $7.2 billion. These figures help illustrate the company's solid financial health and capability for future growth.

Undervalued Stock Potential

According to current metrics, FOX Corp. holds a P/E Ratio (Adjusted) of 12.3 for the last twelve months, suggesting that the stock may be undervalued concerning its earning potential. Moreover, the company reported total revenues of $13.98 billion USD and maintained an Operating Income Margin of 17.47% over the previous year.

Dividend Payout and Shareholder Commitment

For those investors seeking income through dividends, FOX Corp. presents an appealing Dividend Yield of 1.29%, accompanied by a notable Dividend Growth of 8.0% during the last year. This growth reflects a consistent increase in dividends paid to shareholders, with the company successfully raising its dividend for four consecutive years, showcasing a commitment to delivering returns to investors.

Frequently Asked Questions

What is Guggenheim's new target price for FOX Corp.?

Guggenheim has increased the target price for FOX Corp. to $50 from $45 based on strong Q1 results.

How did FOX Corp. perform in the recent quarter?

FOX Corp. reported a significant 11% revenue growth and an EPS of $1.78 in the recent quarter, exceeding analysts' expectations.

What contributed to FOX Corp.'s revenue growth?

The growth was driven by record political advertising revenue and improvements in affiliate revenue due to pricing strategies.

What is FOX Corp.'s current dividend yield?

FOX Corp. offers a Dividend Yield of 1.29% with a consistent growth rate over the past year.

How has the stock been performing overall?

The stock shows signs of being undervalued based on its P/E Ratio of 12.3 and positive growth indicators.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

OSF Digital Welcomes Simon Mulcahy as Executive Advisor for Growth

Updated Category News Views 235

OSF Digital Welcomes Simon Mulcahy as Executive Advisor OSF Digital is thrilled to announce the appointment of Simon Mulcahy as its new Executive Advisor, a move aimed at fostering AI-powered innovation and growth within the company. With an impressive background that includes serving as former Chief Innovation Officer at Salesforce, Simon will collaborate closely with...

Continue Reading
7-Eleven's Brands with Heart Showcase: A Launchpad for Innovation

Updated Category News Views 301

7-Eleven’s Innovative Brands with Heart Showcase Opens Applications Applications are now welcomed for creative, retail-ready goods that cater to today's consumer needs. 7-Eleven, Inc., recognized as the largest convenience retailer globally, has launched the applications for its annual Brands with Heart™ showcase. This unique initiative allows promising brands to...

Continue Reading
Advancing Women's Health: A Grant for Innovative Research

Updated Category News Views 95

Transformative Research for Women's Health The landscape of women's healthcare is undergoing a paradigm shift thanks to groundbreaking research initiatives supported by grants aimed at enhancing interventional radiology treatments. One notable effort is the recent award given to Dr. Wendaline M. VanBuren, a radiologist at Mayo Clinic, recognized for her commitment to...

Continue Reading
Canada's Inflation Rate Dips to 1.6%: A Closer Look

Updated Category News Views 150

Understanding Canada's Recent Inflation Trends The annual inflation rate in Canada has seen a notable decline, landing at 1.6% in September. This decrease is primarily attributed to falling gasoline prices, a change that has taken many analysts by surprise. Key Factors Behind the Decline The recent data from Statistics Canada suggests that the inflation rate fell more...

Continue Reading
Ace Hardware Maintains Top Tier Status with Market Growth

Updated Category News Views 92

Ace Hardware locked down its fifth spot in the Franchise Times Top 400 back in 2023, holding steady for three years running. That's not just a number; it's a signal of strength in a market full of ups and downs. Retail sales hit $23.3 billion that year, bumping up by 0.6% from the previous reporting period—nothing to sneeze at given how volatile retail can get. Sales...

Continue Reading